Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Jul 16, 2025; 17(7): 107790
Published online Jul 16, 2025. doi: 10.4253/wjge.v17.i7.107790
Is endoscopic treatment a useful therapeutic option for esophageal gastrointestinal stromal tumors?
Beata Jabłońska
Beata Jabłońska, Department of Digestive Tract Surgery, Medical University of Silesia, Katowice 40-752, Poland
Author contributions: Jabłońska B contributed to conceptualization, data curation, literature review, formal analysis, investigation, validation, writing and editing the manuscript.
Conflict-of-interest statement: No conflicts of interest to declare.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Beata Jabłońska, MD, PhD, Adjunct Professor, Department of Digestive Tract Surgery, Medical University of Silesia, Medyków 14, Katowice 40-752, Poland. bjablonska@poczta.onet.pl
Received: March 30, 2025
Revised: April 10, 2025
Accepted: May 7, 2025
Published online: July 16, 2025
Processing time: 102 Days and 19.1 Hours
Core Tip

Core Tip: Decisions regarding the management of patients with esophageal gastrointestinal tumors (EGISTs) are very challenging, as there are still no clear guidelines on the treatment of these tumors due to their rarity. Currently, surgery remains the mainstay treatment in patients with EGISTs. Recently, the endoscopic approach has been introduced as a less invasive, but safe and effective treatment option for low-risk EGISTs.